Full Description
AI-Powered Drug Delivery to Neuro and Cardiovascular Systems: Perspectives and Future Challenges is a comprehensive reference covering the transformative potential of Artificial Intelligence (AI) in the realms of neuro and cardiovascular drug delivery. Designed to integrate and review the latest literature, this book provides an in-depth understanding of how AI is set to revolutionize clinical practices, protocols, and regulatory guidelines in therapeutic drug delivery. As AI and robotics continue to evolve, their role in enhancing precision, personalization, and efficiency in cardiovascular and neurological drug delivery becomes increasingly essential. The book opens with an introduction to the foundational concepts of AI in drug delivery, followed by a detailed examination of current AI practices in managing cardiovascular and neurological diseases. It progresses to explore AI-enhanced drug design and testing for cardiovascular conditions, and the application of AI in cardiac drug delivery vehicles. Insights into bioengineered heart and vessels, AI-inspired redox homeostasis, and targeted drug replenishment in cardiac matrix remodeling are thoroughly discussed. The text also covers novel avenues in mitochondrial drug retention, AI-assisted pharmaco and gene therapy for neurodegenerative diseases, and the role of AI in heart health. Further sections address the augmented optimization of medical side effects, neuromodulation with pharmacotherapy from an AI perspective, and smart systems for managing cerebrovascular accidents. The book concludes with a discussion on translational challenges and future directions in the field. This book is an invaluable resource for healthcare professionals, researchers, and students keen on understanding the dynamic interplay between AI and drug delivery systems. By offering insights into AI-driven prediction models, personalized drug regimens, and advanced robotic delivery mechanisms, it sets the stage for the next generation of cardiovascular and neurotherapeutic management. The perspectives, concepts, and innovations discussed are integral to shaping the future of cardiovascular and neurological healthcare.
Contents
1. Introduction
Section I: Fundamentals and concepts
2. AI and ML in translational drug delivery.
3. Current AI practices in the management of cardiovascular and neurological diseases.
4. AI-enhanced drug design and testing for cardiovascular diseases.
Section II: AI-supported drug delivery
5. Artificial intelligence in cardiac drug delivery vehicles
6. Bioengineered heart and vessels: Insights on AI-based drug release approaches.
7. AI-inspired redox homeostasis of cardiovascular system: Next-gen drug therapy
8. AI-targeted drug replenishment in cardiac matrix remodeling and regeneration.
9. Mitochondrial drug retention: Novel avenues in AI
10. AI-assisted pharmaco and gene therapy for neurodegenerative diseases
11. Neuromodulation with pharmacotherapy: An AI perspective
Section III: Management and future
12. AI in Heart Health
13. Augmented optimization of medical side effects - avoiding the crisis of complication.
14. Smart systems for the management of cerebrovascular accidents.
15. Translational challenges and future.
